Nvidia’s continued H20 chip sales to China will benefit Samsung, SK Hynix
Nvidia has received approval from the US government to resume exports of its H20 graphics processing unit (GPU) to China,…
TSMC in crosshairs: tariffs, currency, and AI growth at stake
As TSMC prepares to deliver its earnings report on July 17, all eyes are on how the world’s largest contract…
John Ternus emerges as Tim Cook’s potential successor
John Ternus, once a relatively low-profile executive at Apple, is now considered by the rumor mill as the leading candidate…
Nvidia regains China access as Trump reverses H20 ban, but at what cost?
Nvidia CEO Jensen Huang is engaging in a high-stakes diplomatic and commercial push across Washington and Beijing, positioning artificial intelligence…
GlobalFoundries takes MIPS under its wing; Imagination shoots down SMIC takeover talk
With TSMC commanding the lion’s share of foundry orders for data center AI accelerators, second-tier players like UMC, GlobalFoundries (GF),…
Taiwan’s e-commerce platforms struggle while service providers thrive
Taiwan’s leading e-commerce platforms have been struggling amid the fading post-pandemic boom and heightening competition, with market leader Fubon Multimedia…
D-Link reports success in Middle East market; 5G CPE shipments to reach 150,000 units in 2025
As the global telecommunications market accelerates 5G network deployment, demand for 5G customer premises equipment (CPE) continues to rise. Taiwanese…
Broadcom’s plant investment in Spain reportedly canceled, dealing blow to Southern Europe’s chip ambitions
Broadcom has reportedly scrapped its plan to invest US$1 billion in an assembly, test, and packaging (ATP) facility in Spain.…
Pneumococcal Vaccination Linked With Reduced COVID-19 Hospitalization, Death in Inflammatory Rheumatic Diseases
Patients with inflammatory rheumatic diseases may have a protective effect against serious COVID-19 outcomes once they receive a pneumococcal vaccination.
ATOPP 2025: Navigating Biosimilar Adoption and Operational Strategies in Oncology
Laura R. Bobolts, PharmD, BCOP, shares actionable strategies for oncology pharmacists to navigate biosimilar and 505(b)(2) drug implementation, manage payer…